Research Article
Usefulness of Measuring Thiopurine Metabolites in Children with Inflammatory Bowel Disease and Autoimmunological Hepatitis, Treated with Azathioprine
Table 1
Background information about the group receiving azathioprine.
| | Characteristics | Values |
| | Total number of patients | 61 | | Females (percent) | 27 (44%) | | Age () | | | Crohn’s disease (CD) | 31 (50%) | | Ulcerative colitis (UC) | 16 (26%) | | Autoimmune hepatitis (AIH) | 14 (23%) | | Weight SDS () | | | CD | | | UC | | | AIH | | | Height SDS () | | | CD | | | UC | | | AIH | | | BMI SDS () | | | CD | | | UC | | | AIH | | | Premonitoring azathioprine dose mg/kg () | | | CD | | | UC | | | AIH | | | Postmonitoring azathioprine dose mg/kg () | | | CD | | | UC | | | AIH | | | 6-TGN () | | | CD | | | UC | | | AIH | | | 6-MMP () | | | CD | | | UC | | | AIH | | | Disease activity: | | | Remission/mild form of IBD | 32 (68%) | | Moderate form of IBD | 10 (21%) | | Severe form of IBD | 5 (11%) | | Remission of AIH | 14 (100%) |
|
|
SD: standard deviation; 6-MMP: 6-methylmercaptopurine; 6-TGN: 6-thioguanine; IBD: inflammatory bowel disease; AIH: autoimmunological hepatitis; CD: Crohn’s disease; UC: ulcerative colitis.
|